(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

AUREGEN BIOTHERAPEUTICS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

AUREGEN BIOTHERAPEUTICS

ST13

US500000090609749

Classe

1, 5, 7, 9, 10, 40, 42, 44

Pedido

90609749

Registro

7602926

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

50

Atualização mais recente

03/06/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 7, 9, 10, 40, 42, 44

Data de depósito

29/03/2021

Data de registro

17/12/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

17/12/2024

Última transação

03/06/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

Geneva, CH

Examinador

SHOOR, AMIT

Localização atual

Historical data usage

Titulares e representantes

Titulares

Auregen BioTherapeutics SA

Representantes

LEIGH ANN LINDQUIST SUGHRUE MION, PLLC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 7Classe 9Classe 10Classe 40Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Stem cells for research purposes; stem cells for scientific purposes; stem cells for research or scientific purposes; stem cells other than for medical or veterinary purposes; hydrogel polymer edible coatings for tablets; Lactic acid polymers for use in the manufacture of capsules for pharmaceuticals; Aqueous linear polymer gels for use in the manufacture of capsules for pharmaceuticals; Chemical preparations in the nature of photo curable resin compositions comprising polymers for scientific purposes; chemicals for use in polymerisations; engineered biological tissues and tissue arrayshuman and animal organconnectiveepithelialmuscularnervous tissues and tissue arraysfor use in scientific and medical research; biologically compatible materialshydrogels used to create polymeric networks used in the manufacture of living tissue for research and scientific purposes; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment

Classe 5

Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs for replacing and/or for supporting the function of missing or damaged body parts; Medical preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs for medical use; tissue-regenerative pharmaceutical preparations; Biological boneskin tissue intended for subsequent implantation for skin and cartilage; biological skin and cartilage tissue intended for subsequent implantation; cells for medical use; human allograft tissue; living cells for medical use; Surgical implants comprised of living tissues for guided tissue regeneration; implants comprising living tissue; Implants comprised of living tissue for use in guided tissue regeneration; skin grafts; surgical implants comprised of living tissues; surgical implants of living tissues grown from stem cells; transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Implants comprised of living tissues for transplant; antibodies for use to create skin for prosthetic limbs and for skin grafts; stem cells for medical purposes; engineered biological tissues and organshuman and animal cardiovascularpulmonarydigestivehepatobiliaryurologicalrenalendocrineconnectiveepithelialmuscularnervous tissue and organsfor medical purposes; biological molecules to assist in the development of tissue for medical purposes; hemostatic gel matrix preparations for treating wounds; natural biomaterials for augmentation of boneblood and tissue for medical purposes; processed human donor skin for the replacement of soft tissue; pharmaceutical products for tissue regenerationfor tissue repairfor tissue treatmentwhether relating to human or animal tissue; pharmaceutical preparations for the treatment of bone diseasesfor cartilaginous diseasesfor vascular diseasesfor neuronal degenerationfor degeneration of tendons and ligamentsfor retinal degenerationfor renal degenerationdegeneration of soft tissuefor diseases with abnormal cell proliferation; natural biomaterials for bone filling for medical purposes; natural biomaterials for filling cartilage for medical purposes; stem cells for medical use; surgical implants of living tissue; surgical cloths for wound protection; surgical implants grown from stem cells and comprised of living tissue; biological tissue cultures for medical useall the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment; Cartridges containing printing material for use with three dimensional printersfilled with natural biomaterials for augmentation of bone and tissue for medical purposes; Cartridges for use with three dimensional printers filled bioprinting material in the nature of living tissue for medical purposes; printing cartridges for use with three dimensional printerscontaining bioink in the nature of living tissue for medical purposes

Classe 7

Three-dimensional (3D) printers; three-dimensional (3D) bioprinters; Machines in the nature of computerized equipment for the generation of three-dimensional shaped parts; machines for manufacturing three dimensional modelscomputer-aided modeling devices; machines for manufacturing three dimensional (3D) living tissues; machinesthree dimensional (3D) bioprinter for the printing of living tissues; cartridges for containing printing material for use with three dimensional printerssold empty; cartridges for containing bioprinting material for use with three dimensional printerssold empty; printing cartridges for containing biomaterial for use with three dimensional printerssold empty; printing cartridges for containing bioink for use with three dimensional printerssold empty; 3D printers incorporating an imaging device for use in research on biomaterials for the creation of prosthetic limbs and grafts; Combination 3D printers incorporating laboratory apparatus for use in research on biomaterials for the creation of prosthetic limbs and grafts; Combination 3D printers incorporating a scientific research and laboratory apparatus and instruments for research on biomaterials for the creation of prosthetic limbs and grafts in the field of cytology

Classe 9

Laboratory apparatus for fabrication of three-dimensional tissues and organs; Biochips for the production of three-dimensional living tissues and organs for research or scientific purposes; bioreactor for cell culturing; bioreactors for laboratory use; bioreactors for research use; cell culture apparatus for laboratory usecell culture dishestissue culture flasks; Nonmedical combination imaging device incorporating a 3D printer for use in research on biomaterials for the creation of prosthetic limbs and grafts; Laboratory apparatus and instrumentsapparatus and instruments for thermal imagingdetecting pathogensperforming DNA analysisincubatormicroscopefunction generatorsoscilloscopes for use in research on biomaterialsalso incorporating a 3D printerfor the creation of prosthetic limbs and grafts; print heads for inkjet printers; Scientific research and laboratory apparatus and instrumentsapparatus and instruments for thermal imagingdetecting pathogensperforming DNA analysisincubatormicroscopefunction generatorsoscilloscopes for research on biomaterialsalso incorporating a 3D printerfor the creation of prosthetic limbs and grafts in the field of cytology; Laboratory apparatus and instrumentsapparatus and instruments for thermal imagingdetecting pathogensperforming DNA analysisincubatormicroscopefunction generatorsoscilloscopes for research on biomaterialsalso incorporating a 3D printerfor the creation of prosthetic limbs and grafts for use in biopharmaceutical discovery and development; Laboratory apparatus and instrumentsapparatus and instruments for thermal imagingdetecting pathogensperforming DNA analysisincubatormicroscopefunction generatorsoscilloscopes for research on biomaterialsalso incorporating a 3D printerfor the creation of prosthetic limbs and grafts; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment

Classe 10

Dental apparatus and instrumentsincluding imaging devicesfor medical purposesfor use in dental surgery; surgical synthetic modified implants and transplants with endogenous materialtissue cells or molecules made of synthetic materials for replacement and/or for supporting the function of missing or damaged body partsnot for cardiac disease treatment; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment; all of the above for synthetic implants

Classe 40

3D printing services for others; Custom 3D printing services; renting of 3D printers; creation of customized three-dimensional shaped parts using rapid prototyping equipment; 3D bioprinting for others; Bioprinting for others; Research in the field of three-dimensional (3D) printing in the nature of bioprinting for others; Technical consultancy in the field of rapid prototype fabrication of new products for others

Classe 42

Technical research in the fields of biomimeticsbiomaterialsmaterial adaptation3D bioprinting and tissue engineering; research and development of medical devices; research in the field of nanotechnology and nanomaterials; synthetic biology research; robotics research; bioengineering research; nanotherapeutics research; Biological research in the field of three-dimensional (3D) bioprinting; tissue engineering research; research and development of 3D technology and processes; development of rapid prototyping equipment; scientific research consulting in the fields of three-dimensional printing; scientific services relating to the isolation and cultivation of human tissues and cells; scientific and medical research and development in the field of bio-printing; scientific and medical research and development in the field of tissue manufacturing; Tissue engineering in the nature of development and culture of artificial tissues and cells; Tissue engineering services in the nature of development and culture of artificial tissues and cells for scientific and research purposes; Scientific and medical research and analysis services in the field of tissue engineering researchregenerative biotherapiesgenomicsbiotechnologychemicals and pharmaceuticals; Scientific research and material testing services in the fields of regenerative biotherapiesgenomicsbiotechnologychemicals and pharmaceuticals; research and development of new products for others in the fields of regenerative biotherapiesgenomicsbiotechnologychemicals and pharmaceuticals; Autologous and allogeneic tissue engineering in the nature of development and culture of artificial tissues and cells for scientific and research purposes; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment

Classe 44

Medical servicesin the field of gene and cellular immunotherapies and transplantation; Medical diagnostic monitoring and reporting of testing services; human cell and tissue banking services; collection and preservation of human blood and cells for medical use; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment; medical treatment services; consulting services in the fields of medical treatment and medicines; medical servicesplastic surgery and microsurgeryin particular reshaping noses (rhinoplasty) for either cosmetic or reconstructive purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

50 publicações encontradas

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

03/06/2025

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

15/05/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/05/2025

ES7R

TEAS SECTION 7 REQUEST RECEIVED

19/12/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

17/12/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

17/12/2024

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

03/07/2024

IUCN

NOTICE OF ALLOWANCE CANCELLED

03/07/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

20/06/2024

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

20/02/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

20/02/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

26/12/2023

PUBO

PUBLISHED FOR OPPOSITION

26/12/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/12/2023

EXPT

EXPARTE APPEAL TERMINATED

20/11/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

20/11/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/10/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/10/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

18/10/2023

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

18/10/2023

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

18/10/2023

GNS1

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

19/07/2023

GNSF

SUBSEQUENT FINAL EMAILED

19/07/2023

CFRC

SUBSEQUENT FINAL REFUSAL WRITTEN

19/07/2023

DOCK

ASSIGNED TO EXAMINER

12/06/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/04/2023

ALIE

ASSIGNED TO LIE

01/04/2023

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

24/03/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

13/03/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

13/03/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/03/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

13/09/2022

GNRT

NON-FINAL ACTION E-MAILED

13/09/2022

CNRT

NON-FINAL ACTION WRITTEN

13/09/2022

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/07/2022

GNFR

FINAL REFUSAL E-MAILED

07/07/2022

CNFR

FINAL REFUSAL WRITTEN

07/07/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/05/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/05/2022

ALIE

ASSIGNED TO LIE

16/05/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/05/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/11/2021

GNRT

NON-FINAL ACTION E-MAILED

10/11/2021

CNRT

NON-FINAL ACTION WRITTEN

10/11/2021

DOCK

ASSIGNED TO EXAMINER

08/11/2021

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

11/08/2021

ALIE

ASSIGNED TO LIE

11/08/2021

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

06/08/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/07/2021

NWAP

NEW APPLICATION ENTERED

01/04/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace AUREGEN BIOTHERAPEUTICS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.